RCBTB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.132400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.565000E-01
Normal-vs-Stage2
1.344450E-03
Normal-vs-Stage3
6.135600E-03
Normal-vs-Stage4
4.079600E-02
Stage1-vs-Stage2
2.328400E-01
Stage1-vs-Stage3
7.252000E-02
Stage1-vs-Stage4
3.332200E-01
Stage2-vs-Stage3
1.199810E-01
Stage2-vs-Stage4
6.841000E-01
Stage3-vs-Stage4
1.511810E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.382000E-02
Normal-vs-AfricanAmerican
6.878500E-02
Normal-vs-Asian
3.416700E-03
Caucasian-vs-AfricanAmerican
6.596400E-01
Caucasian-vs-Asian
1.585770E-01
AfricanAmerican-vs-Asian
1.358970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.978200E-03
Normal-vs-Female
1.835780E-02
Male-vs-Female
9.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.268800E-01
Normal-vs-Age(41-60Yrs)
4.019900E-02
Normal-vs-Age(61-80Yrs)
4.064600E-03
Normal-vs-Age(81-100Yrs)
5.416400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.555200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.740000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.679400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.046300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.347000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.882200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.201700E-04
Normal-vs-Daily Drinker
1.984300E-03
Normal-vs-Weekly Drinker
4.483200E-03
Normal-vs-Occasional Drinker
1.197630E-01
Normal-vs-Social Drinker
1.803800E-01
Non Drinker-vs-Daily Drinker
5.935800E-01
Non Drinker-vs-Weekly Drinker
7.329200E-01
Non Drinker-vs-Occasional Drinker
9.189500E-02
Non Drinker-vs-Social Drinker
3.337800E-01
Daily Drinker-vs-Weekly Drinker
9.093800E-01
Daily Drinker-vs-Occasional Drinker
4.920400E-02
Daily Drinker-vs-Social Drinker
2.394600E-01
Weekly Drinker-vs-Occasional Drinker
1.066790E-01
Weekly Drinker-vs-Social Drinker
2.874200E-01
Occasional Drinker-vs-Social Drinker
7.943000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.090970E-01
Normal-vs-Grade 2
5.983600E-03
Normal-vs-Grade 3
1.943960E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.399410E-01
Grade 1-vs-Grade 3
1.662010E-01
Grade 1-vs-Grade 4
1.090970E-01
Grade 2-vs-Grade 3
9.488000E-01
Grade 2-vs-Grade 4
5.983600E-03
Grade 3-vs-Grade 4
1.943960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.856000E-03
Normal-vs-NonDiabetic
1.569670E-02
Diabetic-vs-NonDiabetic
5.925600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.408700E-04
Normal-vs-NoPancreatitis
1.835530E-02
Pancreatitis-vs-NoPancreatitis
1.097240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.272100E-02
Normal-vs-N1
2.060700E-03
N0-vs-N1
3.833400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.918300E-03
Normal-vs-TP53-NonMutant
1.509810E-01
TP53-Mutant-vs-TP53-NonMutant
4.710400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
